[
    [
        {
            "time": "",
            "original_text": "【东吴医药】周观点20200322：国产新冠疫苗研发和国际同步，建议关注康希诺、复星医药、智飞生物",
            "features": {
                "keywords": [
                    "新冠疫苗",
                    "研发",
                    "国际同步",
                    "康希诺",
                    "复星医药",
                    "智飞生物"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【东吴医药】周观点20200322：国产新冠疫苗研发和国际同步，建议关注康希诺、复星医药、智飞生物",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        },
        {
            "time": "",
            "original_text": "重磅新品陆续获批 疫情扰动不改疫苗龙头长期增长趋势",
            "features": {
                "keywords": [
                    "重磅新品",
                    "获批",
                    "疫情",
                    "扰动",
                    "疫苗龙头",
                    "长期增长趋势"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "重磅新品陆续获批 疫情扰动不改疫苗龙头长期增长趋势",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 7,
                "Duration": 9,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        }
    ]
]